LIXTE Biotechnology Holdings (NASDAQ: LIXT) is sponsoring the inaugural Good Health: Mind, Body & Soul Summit, an invitation-only event scheduled for Feb. 19 at Morehouse College in Atlanta. The summit, inspired by the music and legacy of De La Soul, brings together leaders in health, culture, science, and community to advance health equity for Black men and families. Developed in collaboration with Blacksmith holdings, the program reflects De La Soul's evolution from musical pioneers to wellness advocates and will feature discussions on cancer, heart disease, mental health, addiction, sleep, relationships, and intergenerational wellness.
LIXTE said the summit aligns with its mission as a clinical-stage pharmaceutical company advancing cancer care through its first-in-class oncology compound LB-100 and its European research subsidiary, LIORA. The company aims to create a space to connect scientific innovation with communities most impacted by health disparities. According to the press release, the summit is rooted in De La Soul's song "Good Health," written following the passing of founding member David Jolicoeur (Trugoy the Dove).
LIXTE Biotechnology Holdings is a clinical-stage pharmaceutical company focused on new targets for cancer drug development. Its lead compound, LB-100, is a first-in-class PP2A inhibitor that has been shown in clinical trials to be well-tolerated in cancer patients at doses associated with anti-cancer activity. Based on extensive published preclinical data (see www.lixte.com), LB-100 has the potential to significantly enhance chemotherapies and immunotherapies and improve outcomes for patients with cancer. Proof-of-concept clinical trials are currently in progress for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer.
The summit underscores LIXTE's commitment to addressing health disparities that disproportionately affect Black communities. By partnering with De La Soul and Morehouse College, LIXTE aims to foster dialogue on critical health issues while highlighting the importance of scientific innovation in cancer care. The event is invitation-only and will feature leaders in health, culture, science, and community. For more details on the summit, the full press release is available at https://ibn.fm/0kkqK.
